Systemic Lupus Erythematosus: Which Drugs and When?
Therapy traditions and available therapeutics have evolved slowly, but surely, and are gradually changing the prognosis in patients with SLE for the better. Further refinements in therapeutic strategies, including 'treating-to-target', and several new biologic agents currently being developed will almost certainly enable physicians to achieve even better results for their patients in the future.
Conclusion
Therapy traditions and available therapeutics have evolved slowly, but surely, and are gradually changing the prognosis in patients with SLE for the better. Further refinements in therapeutic strategies, including 'treating-to-target', and several new biologic agents currently being developed will almost certainly enable physicians to achieve even better results for their patients in the future.